Related by context. Frequent words. (Click for all words.) 73 Panzem R 72 factor VIIa 72 Factor VIIa 71 liposomal formulation 71 Nanobody 70 TELINTRA 70 JAK inhibitor 69 AEG# 69 systemically administered 69 Copegus R 69 TLR9 agonist 69 refractory chronic lymphocytic 69 PEG SN# 69 CORT # 68 orally bioavailable 68 Initiates Phase II 68 R sorafenib tablets 68 Thiarabine 68 therapeutic monoclonal antibodies 68 selective inhibition 68 cancer immunotherapies 68 INT# [002] 68 MKC# 68 inflammatory autoimmune diseases 67 personalized immunotherapy 67 epothilone 67 antisense drug 67 novel anticancer 67 ALN TTR 67 theranostic 67 agent VDA 67 humanized antibody 67 MEK inhibitor 67 forodesine 67 Celator 67 proteasome inhibitor 67 inhaled formulation 67 siRNA therapeutics 66 thymalfasin 66 nicotinic alpha 7 66 deforolimus 66 Onalta 66 Bicifadine 66 Locteron ® 66 elotuzumab 66 SERMs 66 Azedra 66 novel antibody therapeutics 66 Mipomersen 66 immuno inflammatory diseases 66 Entereg R 66 anticancer compounds 66 Hybridon 66 Tarvacin TM 66 multi kinase inhibitor 66 PEGylated 66 IMC #B 66 targeting CD# 66 selectively inhibit 66 PARI Pharma 66 Meets Primary Endpoint 66 GRNVAC1 66 Prodarsan ® 66 polyclonal antibody 66 SARMs 66 chemokine receptor 66 AzaSite Plus 66 polymerase inhibitors 66 Ramoplanin 66 HCV protease inhibitor 65 novel RNAi therapeutics 65 Kuvan R 65 Chrysalin 65 LEX System 65 Vandetanib 65 vosaroxin 65 JAK1 65 Recombinant Human 65 nitric oxide donating 65 ApoB SNALP 65 HCV protease 65 Vaccinex 65 molecular biomarkers 65 derived neurotrophic factor 65 EyeGate 65 B lymphocyte stimulator 65 PLK1 SNALP 65 Triolex 65 Aurexis 65 pertuzumab 65 KNS # 65 histone deacetylase 65 Pervasis 65 peptide therapeutics 65 Daclizumab 65 Aegera 65 TLR8 65 New Chemical Entities 65 Alinia 65 otelixizumab 65 active cellular immunotherapy